(Q30885642)

English

Predicting the HER2 status of breast cancer from basic histopathology data: an analysis of 1500 breast cancers as part of the HER2000 International Study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Predicting the HER2 status of breast cancer from basic histopathology data: an analysis of 1500 breast cancers as part of the HER2000 International Study (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

author name string

Bilous M

1

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Ades C

2

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Armes J

3

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Bishop J

4

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Brown R

5

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Cooke B

6

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Cummings M

7

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Farshid G

8

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Field A

9

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Morey A

10

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

McKenzie P

11

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Raymond W

12

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Robbins P

13

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Tan L

14

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

publication date

1 April 2003

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

92-98

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2802%2900273-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluating HER2 amplification and overexpression in breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2802%2900273-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2802%2900273-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2802%2900273-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2802%2900273-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated soluble c-erbB-2 antigen levels in the serum and effusions of a proportion of breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2802%2900273-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2802%2900273-4

7 January 2021

based on heuristic

inferred from DOI database lookup

HER-2/neu protein expression in breast cancer evaluated by immunohistochemistry. A study of interlaboratory agreement

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2802%2900273-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): a study of incidence and correlation with outcome in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2802%2900273-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2802%2900273-4

7 January 2021

based on heuristic

inferred from DOI database lookup

HER2 testing recommendations in Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2802%2900273-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A formalin-fixed, paraffin-processed cell line standard for quality control of immunohistochemical assay of HER-2/neu expression in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2802%2900273-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Her-2/neu analysis in archival tissue samples of human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2802%2900273-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of the need and appropriate method for testing for the human epidermal growth factor receptor-2 (HER2).

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2802%2900273-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2802%2900273-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2802%2900273-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Consistency of histopathological reporting of breast lesions detected by screening: findings of the U.K. National External Quality Assessment (EQA) Scheme. U. K. National Coordinating Group for Breast Screening Pathology.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2802%2900273-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Implications of pathologist concordance for breast cancer assessments in mammography screening from age 40 years

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2802%2900273-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0960-9776(02)00273-4

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30885642&oldid=1546802345"